Biocept Q1 Revenues Rise on Test Volume Increases | GenomeWeb

NEW YORK (GenomeWeb) - Biocept reported after the close of the market Thursday that its first quarter revenues increased 47 percent year over year, primarily due to growing commercial test volume.

For the three months ended March 31, the company's total revenues rose to $221,369 from $150,002 the prior year's quarter.

The liquid biopsy firm said it tested 810 billable samples during the first quarter of 2016, up from 289 billable cases during the first quarter of 2015.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.